TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ARCT

Arcturus Therapeutics Holdings Inc

Healthcare · Biotechnology

14.40$ -2.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ARCT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-156.6%
+64.5% +19.6% +572.1% +42.0% +17.5% +28.9% +35.3% +28.0% +93.6% +19.9% -14.6%
-42.2% +5.7% -13.2% -42.0% +57.4% +241.3% +327.5% +5.9% +13.2% +9.6% -33.1%
-91.7% +149.3% +215.7% -40.1% +78.5% +136.9% +435.3%
-387.4% +175.0% -115.7% +32.7% +53.8% -138.5% -381.9%
+129.1% -59.1% +239.2% +488.8% -44.7% +113.0% +95.5% +126.8% -62.5% -77.7% -64.5%
-502.5% +112.1% +113.8% -103.7% +113.0% +95.5% +126.8% -62.5% -77.7% -64.5%
+0.0% -98.0% +0.0% -75.4% +11,033.1% +1,054.0% -99.7%
+199.7% +0.0% +74.7% -49.9% +842.3% +0.0% -110.7% +447.3% -100.0%
+0.0% -100.0% +116,533.3% +45.8% +310.7% +940.7% -89.0% -106.0% +742.5% +147.0%
-199.1% -31.5% +199.2% +1,030.2% -123.1% -310.6%
-186.5%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?